Total population | Gout and asymptomatic hyperuricemia | Gout | Asymptomatic hyperuricemia | |
---|---|---|---|---|
0–18 years | ||||
All, n (%) | 696,277 | 276 (0.040) | 48 (0.007) | 228 (0.033) |
Male, n (%) | 356,790 | 209 (0.059) | 33 (0.009) | 176 (0.049) |
Female, n (%) | 339,487 | 67 (0.020) | 15 (0.004) | 52 (0.015) |
0–5 years | ||||
All, n (%) | 220,749 | 22 (0.010) | 3 (0.001) | 19 (0.009) |
Male, n (%) | 113,406 | 10 (0.009) | 1 (< 0.001) | 9 (0.008) |
Female, n (%) | 107,343 | 12 (0.011) | 2 (0.002) | 10 (0.009) |
6–11 years | ||||
All, n (%) | 219,509 | 43 (0.020) | 7 (0.003) | 36 (0.016) |
Male, n (%) | 112,561 | 23 (0.020) | 2 (0.002) | 21 (0.019) |
Female, n (%) | 106,948 | 20 (0.019) | 5 (0.005) | 15 (0.014) |
12–18 years | ||||
All, n (%) | 256,019 | 211 (0.082) | 38 (0.015) | 173 (0.068) |
Male, n (%) | 130,823 | 176 (0.135) | 30 (0.023) | 146 (0.112) |
Female, n (%) | 125,196 | 35 (0.028) | 8 (0.006) | 27 (0.022) |